A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation C in Healthy Adults

The goal of this study is to learn how safe V118 Formulation C is in Healthy Adults and how well people tolerate it.

The main inclusion criteria include but are not limited to the following:

• Is in good health before randomization

Exclusion Criteria:

• Has a history of invasive pneumococcal disease or known history of other culture-positive pneumococcal disease within 3 years prior to receiving study vaccination.
• Has a history of clinically significant endocrine, GI, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.